entertainment -WSS

entertainment

author：explore 2025-10-01 01:53:54 - browse：39

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： What causes rare myocarditis in young men after Covid vaccines?

knowledge

WSS

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

What causes rare myocarditis in young men after Covid vaccines?

New lawsuit accuses health insurer Cigna of denying claims in bulk

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

New Alzheimer's drugs heat up race for early detection blood tests

knowledge

entertainment

focus

ChatGPT in medicine: STAT answers readers' burning questions

The Harvard botanist who searched for psychedelics in the Amazon

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A new crop of companies is reshaping the health data economy

Medicare details structure of new drug price negotiation program

Rise in cancer among younger people worries and puzzles doctors

In age of alternative facts, a scholarly course on calling out crap

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Apple is now the first public company to be valued at $3 trillion

STAT readers on older presidents, polypills, Medicare, and more

focus

Former reverend arrested for allegedly killing 8

PBM reform efforts get punted in Congress

Search called off for baby washed away in Pennsylvania flash flood

In the gardens at Boston Children's Hospital, families find sanctuary

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Alabama hospital puts IVF treatments on hold

explore

hotspot

knowledge

focus